NCT01923480

Dosing Study of Amino Acids in Seriously Ill Patients

Determination of the Optimal Infusion Rate of Amino Acids in Seriously Ill Patients

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Baxter Healthcare Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the best rate of infusion of amino acids (15% CLINISOL - sulfite-free (Amino Acid) Injection) for nutrition in subjects with with stages II to IVB head and neck cancer.

Conditions

• Parenteral Nutrition (No Primary Condition Studied)

Interventions

Type	Name	Description
DRUG	15% CLINISOL - Sulfite-free (Amino Acid) Injection
DRUG	15% CLINISOL - Sulfite-free (Amino Acid) Injection
DRUG	15% CLINISOL - Sulfite-free (Amino Acid) Injection

Timeline

• Start date: 2013-07-01
• Primary completion: 2014-12-01
• Completion: 2014-12-01
• First posted: 2013-08-15
• Last updated: 2017-03-27
• Results posted: 2017-03-27

Locations

2 sites across 1 country: United States